Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 238 citing articles:

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Judith A. Seidel, Atsushi Otsuka, Kenji Kabashima
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 1183
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro, Hyun Cheol Chung, Veena Shankaran, et al.
The Lancet Oncology (2016) Vol. 17, Iss. 6, pp. 717-726
Closed Access | Times Cited: 1038
PD-1 and its ligands are important immune checkpoints in cancer
Yinan Dong, Qian Sun, Xinwei Zhang
Oncotarget (2016) Vol. 8, Iss. 2, pp. 2171-2186
Open Access | Times Cited: 295
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
Liève Brochez, Inès Chevolet, Vibeke Krüse
European Journal of Cancer (2017) Vol. 76, pp. 167-182
Open Access | Times Cited: 247
PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
Lihu Gu, Manman Chen, Dongyu Guo, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0182692-e0182692
Open Access | Times Cited: 247
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer
Yoon Young Choi, Hyunki Kim, Su‐Jin Shin, et al.
Annals of Surgery (2018) Vol. 270, Iss. 2, pp. 309-316
Closed Access | Times Cited: 223
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients
Akihito Kawazoe, Takeshi Kuwata, Yasutoshi Kuboki, et al.
Gastric Cancer (2016) Vol. 20, Iss. 3, pp. 407-415
Open Access | Times Cited: 200
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
Yibo Fan, Xiaofang Che, Jinglei Qu, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 11, pp. 3745-3755
Closed Access | Times Cited: 157
Microsatellite instability in Gastric Cancer: Between lights and shadows
Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, et al.
Cancer Treatment Reviews (2021) Vol. 95, pp. 102175-102175
Open Access | Times Cited: 153
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
Roberto Iacovelli, Franco Nolè, Elena Verri, et al.
Targeted Oncology (2015) Vol. 11, Iss. 2, pp. 143-148
Closed Access | Times Cited: 169
Prognostic significance of PD-L1 in solid tumor
Qianqian Wang, Fang Liu, Lei Liu
Medicine (2017) Vol. 96, Iss. 18, pp. e6369-e6369
Open Access | Times Cited: 167
Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
Chan Kim, Eun‐Kyung Kim, Hun Jung, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 141
Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
Changqing Ma, Krishna Patel, Aatur D. Singhi, et al.
The American Journal of Surgical Pathology (2016) Vol. 40, Iss. 11, pp. 1496-1506
Closed Access | Times Cited: 139
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications
Ruri Saito, Hiroyuki Abé, Akiko Kunita, et al.
Modern Pathology (2016) Vol. 30, Iss. 3, pp. 427-439
Open Access | Times Cited: 139
Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection
Shohei Eto, Kozo Yoshikawa, Masaaki Nishi, et al.
Gastric Cancer (2015) Vol. 19, Iss. 2, pp. 466-471
Open Access | Times Cited: 139
The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients
Minghui Zhang, Yuandi Dong, Haitao Liu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 136
Prognostic value of tumor-infiltrating lymphocytes in Epstein–Barr virus-associated gastric cancer
Byung Woog Kang, An Na Seo, Sam S. Yoon, et al.
Annals of Oncology (2015) Vol. 27, Iss. 3, pp. 494-501
Open Access | Times Cited: 129
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
Daniela Lazăr, Mihaela Flavia Avram, I Romoşan, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 32, pp. 3583-3616
Open Access | Times Cited: 128
A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
Zhen Xiang, Jun Li, Shuzheng Song, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 112
Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer
Yaxiong Zhang, Shiyang Kang, Jianfei Shen, et al.
Medicine (2015) Vol. 94, Iss. 6, pp. e515-e515
Open Access | Times Cited: 106
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer
Kohei Yamashita, Masaaki Iwatsuki, Kazuto Harada, et al.
Gastric Cancer (2019) Vol. 23, Iss. 1, pp. 95-104
Open Access | Times Cited: 106
Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer
Kai Liu, Kun Yang, Bin Wu, et al.
Medicine (2015) Vol. 94, Iss. 39, pp. e1631-e1631
Open Access | Times Cited: 105
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
Yeonjoo Choi, Jin Won Kim, Kyung Han Nam, et al.
Gastric Cancer (2016) Vol. 20, Iss. 4, pp. 602-611
Open Access | Times Cited: 97
Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling
Xiaoli Ju, Heng Zhang, Zidi Zhou, et al.
Experimental Cell Research (2020) Vol. 396, Iss. 2, pp. 112315-112315
Open Access | Times Cited: 94
PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
Shijie Xu, Fangbo Cui, Da-Fu Huang, et al.
International Journal of Nanomedicine (2018) Vol. Volume 14, pp. 17-32
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top